ZYDUS GROUP

Company Snapshot

Founded: 1952
Entity Type: Private
Employees: 30,000
Region: U.S.
Revenue: $3,132.30 Millions
Revenue Year: 2025
Headquarter: Gujarat, India
Key Geographics: U.S., India
Corporate Address: Zydus Corporate Park, Scheme No. 63, Khoraj (Gandhinagar), 536, Sarkhej - Gandhinagar Hwy, Near Vaishnodevi Circle, Ahmedabad, Gujarat 382481 India Tel. +91-79-4804-0000 www.zyduslife.com

Company Overview

Zydus Cadila is one of the largest India-based pharmaceutical companies in the world. It is engaged in developing both prescription and generic drugs for a wide range of disease indications. It is also active in the field of medicinal services and supply chain. Zydus Cadila was established in 1952 by Raman Bhai Patel and is headquartered in Ahmedabad, India.

Zydus Cadila is one of the key players in the global pharmaceutical sector, with a strong portfolio of APIs, antibodies, biosimilars, transdermal, topical solutions, animal health and other health products. In 2019, the company started marketing Ramelteon tablets, (marketed in the U.S. as Rozerem tablets) after the sign-off from the FDA. Ramelteon is a narcotic (entrancing molecule) drug indicated to treat sleeping disorders.

As a research-based pharmaceutical organization, Zydus Cadila’s operates an innovation program that involves 1,300 scientists in 19 destinations investigating separate drugs for future possibilities. The vision and mission of Zydus Cadila is to be a leading pharmaceutical organization in India and to evolve into a critical global player by providing high-caliber safety measures and exceptional quality arrangements in medicine and treatment.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

ZYDUS GROUP In Reports

Sleep Disorders Treatment: Global Market Outlook

BCC Research Market Analysis Report says sleep disorders treatment market is projected to grow from $17.2 bln in 2021 to $28.0 bln in 2027, at a CAGR of 8.6%.

Best Selling Pharmaceutical Drugs in 2021

BCC Research Market Analysis Report for Best Selling Pharmaceutical Drugs in 2021. Pharmaceutical Drugs market can grow from $1.3 tln to $1.8 tln in 2027.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2021

BCC Research Market Report for Pharmaceutical Drugs Industry Competitive Landscape of top 50 Pharmaceutical manufacturers in the global market.

Company's Business Segments

  • Pharmaceuticals : This segment includes Research and Development, Manufacturing, Marketing, Distribution of Pharmaceutical Products, including Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations.
  • Consumer Products : This segment includes Research and development, Manufacturing, Marketing, Distribution of Consumer Health and Wellness Products.
  • Medical technologies : It includes precision manufacturing, research and development, clinical collaboration, and global distribution of advanced medical technologies, including cardiovascular intervention devices, diagnostic solutions, and patientcentric healthcare innovations.

Applications/End User Industries

  • Pharmaceuticals
  • Healthcare
  • Consumer Products
  • Vaccines
  • Biologics
  • Oncology
  • Infectious Diseases
  • Active Pharmaceutical Ingredients
  • Marketing
  • Distribution
  • Sweeteners
  • Nutritional Drink
  • Glucose Powder
  • Skincare Products
  • Biosimilar Therapeutic
  • Monoclonal Antibodies
  • Novel Biologics
  • Cardio-Metabolic Diseases
  • Transdermal
  • Animal Health Products
  • Life Sciences
AI Sentiment